Survival of Burkholderia cepacia sepsis following lung transplantation in recipients with cystic fibrosis

Transplant Infectious Disease

Volumn 12, Issue 6, 2010, Pages 551-554

  Nash, E F ^a,b   Coonar, A ^a,c   Kremer, R ^a,c   Tullis, E ^b,d   Hutcheon, M ^a   Singer, L G ^a   Keshavjee, S ^a,c   Chaparro, C ^a,b  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Burkholderia cenocepacia; Burkholderia cepacia complex; Cepacia syndrome; Cystic fibrosis; Lung transplantation; Sepsis; Survival

Indexed keywords

AMIKACIN; AZATHIOPRINE; AZITHROMYCIN; CALCINEURIN INHIBITOR; CEFTAZIDIME; CHLORAMPHENICOL; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; CYCLOSPORIN; DOXYCYCLINE; GANCICLOVIR; MEROPENEM; NYSTATIN; PREDNISONE; TACROLIMUS; TIMENTIN; TOBRAMYCIN; VALGANCICLOVIR;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; BLOOD CULTURE; BRONCHIOLITIS OBLITERANS; BRONCHOSCOPY; BURKHOLDERIA CEPACIA; BURKHOLDERIA CEPACIA INFECTION; CARDIOPULMONARY BYPASS; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CYSTIC FIBROSIS; DRUG SUBSTITUTION; EMPYEMA; EXTUBATION; FEMALE; FORCED EXPIRATORY VOLUME; GRAFT RECIPIENT; GRAFT SURVIVAL; HOSPITAL DISCHARGE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFANT; INFECTION PREVENTION; KIDNEY FAILURE; LONG TERM CARE; LUNG ABSCESS; LUNG LAVAGE; LUNG RESECTION; LUNG TRANSPLANTATION; MAINTENANCE THERAPY; MALE; MORTALITY; NEEDLE BIOPSY; NEPHROTOXICITY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SPUTUM CULTURE; SURVIVAL RATE; THORACOTOMY; TREATMENT DURATION;

ADULT; ANTI-BACTERIAL AGENTS; BURKHOLDERIA CEPACIA COMPLEX; BURKHOLDERIA INFECTIONS; CYSTIC FIBROSIS; EMPYEMA, PLEURAL; FEMALE; HUMANS; LUNG; LUNG ABSCESS; LUNG TRANSPLANTATION; MALE; SEPSIS; SURVIVAL RATE; SURVIVORS; YOUNG ADULT;

EID: 78650080325     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2010.00525.x     Document Type: Article

References (11)

1. Vandamme P, Holmes T, Coenye J, et al. Burkholderia cenocepacia sp. nov. - a new twist to an old story. Res Microbiol 2003; 154: 91-96.
2. Chaparro C, Maurer J, Gutierrez C, et al. Infection with Burkholderia cepacia in cystic fibrosis. Outcome following lung transplantation. Am J Respir Crit Care Med 2001; 163: 43-48.
3. Levine SM. A survey of clinical practice of lung transplantation in North America. Chest 2004; 125: 1224-1238.
4. Isles A, Maclusky I, Corey M, et al. Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J Pediatr 1984; 104: 206-210.
5. Kazachkov M, Lager J, LiPuma J, et al. Survival following Burkholderia cepacia sepsis in a patient with cystic fibrosis treated with corticosteroids. Pediatr Pulmonol 2001; 32: 338-340.
6. Grimwood K, Kidd TJ, Tweed M. Successful treatment of cepacia syndrome. J Cyst Fibros 2009; 8: 291-293.
7. Wiedmann A, Webb AK, Dodd ME, Jones AM. Successful treatment of cepacia syndrome with combination nebulised and intravenous antibiotic therapy. J Cyst Fibros 2008; 7: 409-411.
8. Aaron SD, Ferris W, Henry DA, Speert DP, Macdonald NE. Multiple combination bactericidal testing for patients with cystic fibrosis infected with Burkholderia cepacia. Am J Crit Care Med 2000; 161 (4, Part 1): 1206-1212.
9. De Soyza A, Morris K, McDowell A, et al. Prevalence and clonality of Burkholderia cepacia complex genomovars in UK patients with cystic fibrosis referred for lung transplantation. Thorax 2004; 59: 526-528.
10. Aris RM, Routh JC, LiPuma JJ, Heath DG, Gilligan PH. Lung transplantation for cystic fibrosis patients with Burkholderia cepacia complex. Survival linked to genomovar type. Am J Respir Crit Care Med 2001; 164: 2102-2106.
11. McMenamin JD, Zaccone TM, Coenye T, Vandamme P, LiPuma JJ. Misidentification of Burkholderia cepacia in US cystic fibrosis treatment centers: an analysis of 1, 051 recent sputum isolates. Chest 2000; 117: 1661-1665.